Published in PLoS One on January 23, 2013
CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks. Oncogene (2015) 1.07
CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis. Tumour Biol (2014) 0.92
Stromal derived factor-1 (SDF-1) and its receptors CXCR4 and CXCR7 in endometrial cancer patients. PLoS One (2014) 0.82
Endothelial CXCR7 regulates breast cancer metastasis. Oncogene (2015) 0.81
CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axis. Mol Cancer (2013) 0.79
Allosteric peptide regulators of chemokine receptors CXCR4 and CXCR7. Biochem Pharmacol (2013) 0.76
Luciferase fragment complementation imaging in preclinical cancer studies. Oncoscience (2014) 0.76
Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer. PLoS One (2017) 0.75
High Expression of Stromal Cell-Derived Factor 1 (SDF-1) and NF-κB Predicts Poor Prognosis in Cervical Cancer. Med Sci Monit (2017) 0.75
Beta-arrestins and cell signaling. Annu Rev Physiol (2007) 8.65
CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res (2004) 4.53
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med (2001) 3.81
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood (2009) 3.37
The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol Screen (2004) 2.94
Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci U S A (1999) 2.76
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res (2002) 2.71
CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia (2008) 2.66
The bicyclam AMD3100 story. Nat Rev Drug Discov (2003) 2.59
High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst (2010) 2.56
Near-infrared fluorescent proteins. Nat Methods (2010) 2.52
CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res (2005) 2.38
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J Control Release (2012) 2.12
Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int J Cancer (2008) 2.06
Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalization. J Biol Chem (1999) 2.05
Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. Gynecol Oncol (2004) 2.05
PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment. Cancer Res (2011) 1.87
Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands. Oncogene (2010) 1.69
Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res (2001) 1.61
Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib. Leuk Lymphoma (2009) 1.61
Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol (2006) 1.46
CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas. Clin Cancer Res (2006) 1.42
CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer. Cancer Res (2011) 1.42
Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling. J Clin Invest (2008) 1.41
In vivo imaging of ligand receptor binding with Gaussia luciferase complementation. Nat Med (2011) 1.35
Imaging CXCR4 signaling with firefly luciferase complementation. Anal Chem (2008) 1.32
Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7. Biotechniques (2009) 1.32
The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer. Br J Cancer (2012) 1.25
Dual-color click beetle luciferase heteroprotein fragment complementation assays. Chem Biol (2010) 1.16
Production of stromal cell-derived factor 1 by mesothelial cells and effects of this chemokine on peritoneal B lymphocytes. Eur J Immunol (2001) 1.07
Droplet-based microfluidic system for multicellular tumor spheroid formation and anticancer drug testing. Lab Chip (2010) 1.07
The peritoneal tumour microenvironment of high-grade serous ovarian cancer. J Pathol (2012) 1.07
Inhibition of stromal CXCR4 impairs development of lung metastases. Cancer Immunol Immunother (2012) 1.03
Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4. Neoplasia (2011) 1.00
Microenvironmental regulation of chemokine (C-X-C-motif) receptor 4 in ovarian carcinoma. Mol Cancer Res (2010) 0.97
Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target. J Oncol (2009) 0.92
CXCL12 expression by healthy and malignant ovarian epithelial cells. BMC Cancer (2011) 0.91
Collagenase expression in ovarian cancer cell lines. Gynecol Oncol (1997) 0.87
Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium. Oncogene (2012) 0.87
AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo. Blood Cancer J (2011) 0.85
SDF1/CXCL12 is involved in recruitment of stem-like progenitor cells to orthotopic murine malignant mesothelioma spheroids. Anticancer Res (2010) 0.77
CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res (2004) 4.53
Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood (2003) 3.98
CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci U S A (2007) 3.85
Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals. Proc Natl Acad Sci U S A (2004) 3.59
Optical imaging: current applications and future directions. J Nucl Med (2007) 2.84
Near-infrared fluorescent proteins. Nat Methods (2010) 2.52
Applications of bioluminescence imaging to the study of infectious diseases. Cell Microbiol (2007) 2.31
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J Control Release (2012) 2.12
Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett (2005) 2.11
Imaging 26S proteasome activity and inhibition in living mice. Nat Med (2003) 2.04
Bioluminescence imaging of vaccinia virus: effects of interferon on viral replication and spread. Virology (2005) 1.89
Microfluidic endothelium for studying the intravascular adhesion of metastatic breast cancer cells. PLoS One (2009) 1.87
CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J Exp Med (2011) 1.82
Imaging ligand-dependent activation of CXCR7. Neoplasia (2009) 1.43
Imaging chemokine receptor dimerization with firefly luciferase complementation. FASEB J (2008) 1.42
In vivo imaging of ligand receptor binding with Gaussia luciferase complementation. Nat Med (2011) 1.35
Microfluidic hydrodynamic cellular patterning for systematic formation of co-culture spheroids. Integr Biol (Camb) (2009) 1.33
Imaging CXCR4 signaling with firefly luciferase complementation. Anal Chem (2008) 1.32
TLR3 increases disease morbidity and mortality from vaccinia infection. J Immunol (2008) 1.26
Molecular imaging of gene expression and protein function in vivo with PET and SPECT. J Magn Reson Imaging (2002) 1.21
Applications of bioluminescence imaging to antiviral research and therapy: multiple luciferase enzymes and quantitation. Antiviral Res (2008) 1.18
Microfluidic platform for chemotaxis in gradients formed by CXCL12 source-sink cells. Integr Biol (Camb) (2010) 1.17
Monitoring serial changes in circulating human breast cancer cells in murine xenograft models. Cancer Res (2008) 1.09
Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II. Cell Immunol (2007) 1.05
Generation of a highly inducible Gal4-->Fluc universal reporter mouse for in vivo bioluminescence imaging. Proc Natl Acad Sci U S A (2008) 1.04
A novel, killed-virus nasal vaccinia virus vaccine. Clin Vaccine Immunol (2007) 1.03
Murine alveolar macrophages limit replication of vaccinia virus. Virology (2007) 1.02
In Vivo Monitoring of Multiple Circulating Cell Populations Using Two-photon Flow Cytometry. Opt Commun (2008) 1.02
Protective effect of Toll-like receptor 4 in pulmonary vaccinia infection. PLoS Pathog (2008) 1.02
Type I interferon regulates respiratory virus infected dendritic cell maturation and cytokine production. Viral Immunol (2007) 1.00
Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4. Neoplasia (2011) 1.00
Secreted CXCL12 (SDF-1) forms dimers under physiological conditions. Biochem J (2012) 0.95
Bioluminescence imaging of reporter mice for studies of infection and inflammation. Antiviral Res (2010) 0.95
Development of a baited oral vaccine for use in reservoir-targeted strategies against Lyme disease. Vaccine (2011) 0.94
NanoLuc reporter for dual luciferase imaging in living animals. Mol Imaging (2013) 0.93
Transgenic reporter mouse for bioluminescence imaging of herpes simplex virus 1 infection in living mice. Virology (2006) 0.93
Luciferase protein complementation assays for bioluminescence imaging of cells and mice. Methods Mol Biol (2011) 0.91
Polymeric Aqueous Biphasic System Rehydration Facilitates High Throughput Cell Exclusion Patterning For Cell Migration Studies. Adv Funct Mater (2011) 0.89
Carboxy-terminus of CXCR7 regulates receptor localization and function. Int J Biochem Cell Biol (2012) 0.89
Targeted non-covalent self-assembled nanoparticles based on human serum albumin. Biomaterials (2011) 0.88
Advancing the translation of optical imaging agents for clinical imaging. Biomed Opt Express (2012) 0.86
In vitro and in vivo characterization of a dual-function green fluorescent protein--HSV1-thymidine kinase reporter gene driven by the human elongation factor 1 alpha promoter. Mol Imaging (2003) 0.86
Synthesis and investigation of a radioiodinated F3 peptide analog as a SPECT tumor imaging radioligand. PLoS One (2011) 0.84
Host-derived CD8+ dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantation. Blood (2013) 0.83
Extended cavity laser enhanced two-photon flow cytometry. J Biomed Opt (2008) 0.83
Cell-based and in vivo spectral analysis of fluorescent proteins for multiphoton microscopy. J Biomed Opt (2012) 0.83
Transfer, imaging, and analysis plate for facile handling of 384 hanging drop 3D tissue spheroids. J Lab Autom (2013) 0.82
Imaging pulmonary gene expression with positron emission tomography. Am J Respir Crit Care Med (2002) 0.81
Applications of molecular imaging. Prog Mol Biol Transl Sci (2010) 0.81
Multiplexed spectral signature detection for microfluidic color-coded bioparticle flow. Anal Chem (2010) 0.80
Longitudinal molecular imaging with single cell resolution of disseminated ovarian cancer in mice with a LED-based confocal microendoscope. Mol Imaging Biol (2011) 0.79
Real-time bioluminescence imaging of viral pathogenesis. Methods Mol Biol (2009) 0.79
Analysis of human cellular retinol-binding protein II promoter during enterocyte differentiation. Am J Physiol Gastrointest Liver Physiol (2002) 0.78
Allosteric peptide regulators of chemokine receptors CXCR4 and CXCR7. Biochem Pharmacol (2013) 0.76
Phytochemicals potently inhibit migration of metastatic breast cancer cells. Integr Biol (Camb) (2015) 0.76
CXCR4-Targeted Nanocarriers for Triple Negative Breast Cancers. Biomacromolecules (2015) 0.76
Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells. Mol Imaging (2015) 0.75
Correction: Cell, Isoform, and Environment Factors Shape Gradients and Modulate Chemotaxis. PLoS One (2017) 0.75
Split Gaussia luciferase for imaging ligand-receptor binding. Methods Mol Biol (2014) 0.75
Editor's Recognition Awards. Radiol Imaging Cancer (2022) 0.75
Dispersible oxygen microsensors map oxygen gradients in three-dimensional cell cultures. Biomater Sci (2017) 0.75
2021 Manuscript Reviewers: A Note of Thanks. Radiol Imaging Cancer (2022) 0.75